Long-term surveillance recommendations for young adult cancer survivors

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Katharina Egger-Heidrich - , Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Franziska Wolters - , Universität Hamburg (Autor:in)
  • Mareike Frick - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Teresa Halbsguth - , Universitätsklinikum Frankfurt (Autor:in)
  • Theresa Müller - , Universitäts KrebsCentrum Dresden, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Hannah Woopen - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Kristin Tausche - , Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • Diana Richter - , Universität Leipzig (Autor:in)
  • Judith Gebauer - , Universitätsklinikum Schleswig-Holstein Campus Lübeck, Universität Leipzig (Autor:in)

Abstract

Background: Advancements in cancer treatment have led to increased survival rates among young adult cancer survivors (YACS). However, these individuals face unique long-term health risks, including secondary malignancies, cardiovascular disease, and psychosocial challenges. Effective long-term surveillance strategies are critical to mitigating these risks and improving health outcomes. This scoping review aims to summarize existing recommendations for long-term surveillance of YACS, identify gaps in current guidelines, and highlight areas for future research. Methods: A scoping review was conducted using Pubmed focusing on peer-reviewed literature published between January 2015 and January 2025 that addresses post-treatment (>5 years after diagnosis) follow-up strategies for YACS. The review synthesizes recommendations across various cancer types, treatment modalities, and long-term effects. Results: The review identified 32 recommendations. Of all eligible articles initially retrieved, 169 different articles were included after screening and eligibility. Findings indicate a lack of standardized, age-specific surveillance guidelines, with most recommendations adapted from pediatric or adult oncology frameworks. Emerging evidence suggests that risk-based, personalized surveillance approaches—incorporating genetic predisposition, treatment history, and lifestyle factors—may optimize long-term health outcomes. Discussion: This review underscores the need for age-appropriate, evidence-based surveillance guidelines tailored to YACS and highlights the importance of multidisciplinary care models to support survivorship. Future research should focus on developing standardized, risk-stratified surveillance protocols and evaluating their impact on health outcomes.

Details

OriginalspracheEnglisch
Aufsatznummer102992
Seitenumfang24
FachzeitschriftCancer treatment reviews
Jahrgang139
PublikationsstatusVeröffentlicht - Sept. 2025
Peer-Review-StatusJa

Externe IDs

PubMed 40651064

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Cancer survivorship, Late effects, Young adults